enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Factbox-Top Medicare drugs headed for price cuts - AOL

   www.aol.com/news/factbox-top-medicare-drugs...

   Xarelto. Eliquis rival Xarelto from Johnson & Johnson cost Medicare more than $6 billion between June 2022 and May 2023. The bloodthinner, which was used to treat 1.3 million enrollees, can lower ...

3. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

4. Biden administration says Medicare negotiated price discounts ...

   www.aol.com/biden-administration-says-medicare...

   The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and the insulins Fiasp and NovoLog. The discounts will range from 38% to 79% when the negotiated ...

5. Medicare to kick off first drug price negotiations, and it ...

   www.aol.com/news/medicare-kick-off-first-drug...

   The government is set to begin negotiating prices on the 10 costliest prescription drugs covered by Medicare this week, setting the stage for a fierce tug of war between U.S. officials and drugmakers.

6. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2]

7. Have you been prescribed Entresto or Jardiance? Deep ... - AOL

   www.aol.com/prescribed-entresto-jardiance-deep...

   Xarelto. Prevention and treatment of blood clots; Reduction of risk for patients with coronary or peripheral artery disease. ... "If the negotiated prices had been in effect during 2023, Medicare ...

8. Andexanet alfa - Wikipedia

   en.wikipedia.org/wiki/Andexanet_alfa

   Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation is needed due to uncontrolled bleeding. [8]

9. Medicare to save $6B in 2026 from the first ever Part D drug ...

   www.aol.com/finance/medicare-save-6b-2026-first...

   Xarelto, Johnson & Johnson : $197 per month. ... The newly negotiated prices are, unsurprisingly, lower than the published list prices of the drugs. However, experts have warned that looking at ...